Literature DB >> 15257311

Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions.

Rosemary E Zuna1, Richard A Allen, William E Moore, Rubina Mattu, S Terence Dunn.   

Abstract

High-grade squamous intraepithelial lesions of the cervix are heterogeneous in their invasive potential. Comparison of human papillomavirus types between invasive cervical carcinoma and high-grade squamous dysplasia may provide insight into this biological variability. Liquid-based Pap specimens from 55 high-grade intraepithelial lesions and 47 invasive cervical carcinomas were analyzed by reverse line blot for 27 human papillomavirus types designated high, intermediate, or low risk. Human papillomavirus DNA was present in all high-grade intraepithelial lesions (23 different types) and in 94% (13 types) of invasive carcinomas. High-risk types were present in 81% of invasive carcinomas compared to 58% of high-grade intraepithelial lesions. Severe dysplasias harbored more (79%) high-risk human papillomaviruses as compared to moderate dysplasias (37%). In 40% of high-grade dysplasia cases (59% of moderate dysplasias; 21% of severe) and 13% of invasive carcinomas, intermediate-risk genotypes were identified in the absence of high-risk HPV types. Human papillomavirus 16 was the most common type in all categories, including 47% of high-grade squamous dysplasias (26% moderate; 68% severe) and 61% of invasive carcinomas. Both high-risk type (P=0.0004) and type 16 (P=0.0007) human papillomaviruses were positively associated with increasing severity of diagnosis. The heterogeneous nature of high-grade squamous dysplasias as compared to invasive carcinoma is evident by the wider spectrum of associated human papillomavirus types. Likewise, moderate dysplasia appears to be more heterogeneous in viral type than severe dysplasia. Moderate cases were more often associated with intermediate-risk types, while high-risk types were more prevalent in severe dysplasias and invasive cancers. Moderate dysplasia cases harboring viral types infrequently found in cancers may have a low risk for progression. Human papillomavirus genotyping of high-grade squamous intraepithelial lesions may be important in assessing risk for progression to invasion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257311     DOI: 10.1038/modpathol.3800223

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  19 in total

1.  Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population.

Authors:  Rosemary E Zuna; William E Moore; Rebecca P Shanesmith; S Terence Dunn; Sophia S Wang; Mark Schiffman; Gregory L Blakey; Travis Teel
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

2.  Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer.

Authors:  Dan Song; Hong Li; Haibo Li; Jianrong Dai
Journal:  Oncol Lett       Date:  2015-05-29       Impact factor: 2.967

Review 3.  Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions.

Authors:  Ala-Eddin Al Moustafa; Rana Al-Awadhi; Nabiha Missaoui; Ishag Adam; Raika Durusoy; Lina Ghabreau; Nizar Akil; Hussain Gadelkarim Ahmed; Amber Yasmeen; Ghazi Alsbeih
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Co-presence of human papillomaviruses and Epstein-Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patients.

Authors:  Hamda Al-Thawadi; Ishita Gupta; Ayesha Jabeen; Faruk Skenderi; Tahar Aboulkassim; Amber Yasmeen; Mohammed I Malki; Gerald Batist; Semir Vranic; Ala-Eddin Al Moustafa
Journal:  Cancer Cell Int       Date:  2020-08-03       Impact factor: 5.722

5.  Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: the potential role.

Authors:  Mona Saraiya; Marc T Goodman; S Deblina Datta; Vivien W Chen; Phyllis A Wingo
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

6.  The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancer.

Authors:  Ishita Gupta; Ayesha Jabeen; Reem Al-Sarraf; Hanan Farghaly; Semir Vranic; Ali A Sultan; Ala-Eddin Al Moustafa; Hamda Al-Thawadi
Journal:  Hum Vaccin Immunother       Date:  2020-10-02       Impact factor: 3.452

7.  Pilot study of prevalence of high-risk human papillomavirus genotypes in Israeli Jewish women referred for colposcopic examination.

Authors:  Dan Grisaru; Boaz Avidor; Jacob Niv; Silvia Marmor; Benjamin Almog; Cecilia Leibowitz; Merav Graidy; Michael Giladi
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

8.  HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia.

Authors:  Mariska Bierkens; Saskia M Wilting; Wessel N van Wieringen; Mark A van de Wiel; Bauke Ylstra; Chris J L M Meijer; Peter J F Snijders; Renske D M Steenbergen
Journal:  BMC Cancer       Date:  2012-01-24       Impact factor: 4.430

9.  Locking Src/Abl Tyrosine Kinase Activities Regulate Cell Differentiation and Invasion of Human Cervical Cancer Cells Expressing E6/E7 Oncoproteins of High-Risk HPV.

Authors:  Amber Yasmeen; Amal Alachkar; Hafedh Dekhil; Carlo Gambacorti-Passerini; Ala-Eddin Al Moustafa
Journal:  J Oncol       Date:  2010-08-25       Impact factor: 4.375

10.  VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway.

Authors:  Vivek K Kashyap; Nirnoy Dan; Neeraj Chauhan; Qinghui Wang; Saini Setua; Prashanth K B Nagesh; Shabnam Malik; Vivek Batra; Murali M Yallapu; Duane D Miller; Wei Li; Bilal B Hafeez; Meena Jaggi; Subhash C Chauhan
Journal:  Cancer Lett       Date:  2019-12-03       Impact factor: 9.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.